These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21932010)

  • 1. A patient with Dent disease and features of Bartter syndrome caused by a novel mutation of CLCN5.
    Okamoto T; Tajima T; Hirayama T; Sasaki S
    Eur J Pediatr; 2012 Feb; 171(2):401-4. PubMed ID: 21932010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteinuria in Dent disease: a review of the literature.
    van Berkel Y; Ludwig M; van Wijk JAE; Bökenkamp A
    Pediatr Nephrol; 2017 Oct; 32(10):1851-1859. PubMed ID: 27757584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and genetic analysis of 15 Chinese children with dent disease.
    Li Q; Yang Z; Zang R; Liu S; Yu L; Wang J; Wang C; Wang X; Sun S
    Ren Fail; 2024 Dec; 46(1):2349133. PubMed ID: 38726999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotypic variability in patients with clinical diagnosis of Bartter syndrome type 3.
    García-Castaño A; Gómez-Conde S; Gondra L; Herrero M; Aguirre M; de la Hoz AB; Castaño L; ; Madariaga L
    Sci Rep; 2023 Aug; 13(1):12587. PubMed ID: 37537162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antenatal Bartter syndrome: a new compound heterozygous mutation in exon 2 of KCNJ1 gene.
    Mani S; Nair J; Handa D
    BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34663630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-Phenylbutyric Acid Treatment Reduces Low-Molecular-Weight Proteinuria in a
    Perdomo-Ramírez A; Ramos-Trujillo E; Machado JD; García-Nieto V; Mura-Escorche G; Claverie-Martin F;
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and management of Bartter syndrome: executive summary of the consensus and recommendations from the European Rare Kidney Disease Reference Network Working Group for Tubular Disorders.
    Konrad M; Nijenhuis T; Ariceta G; Bertholet-Thomas A; Calo LA; Capasso G; Emma F; Schlingmann KP; Singh M; Trepiccione F; Walsh SB; Whitton K; Vargas-Poussou R; Bockenhauer D
    Kidney Int; 2021 Feb; 99(2):324-335. PubMed ID: 33509356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-Existence of Congenital Adrenal Hyperplasia and Bartter Syndrome due to Maternal Uniparental Isodisomy of HSD3B2 and CLCNKB Mutations.
    Giri D; Bockenhauer D; Deshpande C; Achermann JC; Taylor NF; Rumsby G; Morgan H; Senniappan S; Ajzensztejn M
    Horm Res Paediatr; 2020; 93(2):137-142. PubMed ID: 32506065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bartter Syndrome Presenting as Arginine-Vasopressin Resistance: A Report of 2 Cases.
    Sousa M; Medeiros R; Rodrigues AL; Dias Pereira B
    Am J Case Rep; 2024 Jun; 25():e942872. PubMed ID: 38885190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dent disease 1-linked novel CLCN5 mutations result in aberrant location and reduced ion currents.
    Wang Y; Xu L; Zhang Y; Fu H; Gao L; Guan Y; Gu W; Sun J; Chen X; Yang F; Lai E; Wang J; Jin Y; Kou Z; Qiu X; Mao J; Hu L
    Int J Biol Macromol; 2024 Feb; 257(Pt 2):128564. PubMed ID: 38061527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal diagnosis of dent disease type I with a nonsense pathogenic variant in CLCN5: a case study.
    Zhu R; Zhu M; Wang B; Chen E; Cai D; Yang Y; Liang Y; Su C; Wang D; Sun X; Huang L; Xie Y
    BMC Med Genomics; 2024 Jan; 17(1):34. PubMed ID: 38267993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel likely pathogenic CLCN5 variant in Dent's disease.
    Hayward S; Norton J; Bownass L; Platt C; ; Campbell H; Watson E; Forrester N; Smithson S; Menon A
    BMC Nephrol; 2023 Aug; 24(1):256. PubMed ID: 37641036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel transgenic mouse model highlights molecular disruptions involved in the pathogenesis of Dent disease 1.
    Sakhi IB; De Combiens E; Frachon N; Durussel F; Brideau G; Nemazanyy I; Frère P; Thévenod F; Lee WK; Zeng Q; Klein C; Lourdel S; Bignon Y
    Gene; 2024 Nov; 928():148766. PubMed ID: 39019097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of pre-mRNA Splicing Defects Caused by
    Mura-Escorche G; Perdomo-Ramírez A; Ramos-Trujillo E; Trujillo-Frías CJ; Claverie-Martín F;
    Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38002082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A patient with cystinosis presenting like bartter syndrome and review of literature.
    Ertan P; Evrengul H; Ozen S; Emre S
    Iran J Pediatr; 2012 Dec; 22(4):543-6. PubMed ID: 23431081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Two Cases of Pseudo-Bartter Syndrome in Childhood: When to Suspect a Rare Onset Pattern of Cystic Fibrosis].
    Vergine G; Fressola G; Ambroni M; Gessaroli M; Bigucci B; Mazzocco M; Conte ML
    G Ital Nefrol; 2024 Jun; 41(3):. PubMed ID: 38943326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent transient severe hypocalcaemia in two siblings with type 1 Bartter syndrome.
    Kanda J; Kanda S; Hayashi Y; Nozu K; Ariji S; Shimoda M; Ono M; Kanda S; Yokoyama S; Takahashi K
    Nephrology (Carlton); 2024 Mar; 29(3):164-167. PubMed ID: 38062639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bartter Syndrome Type 1 Due to Novel
    Kiuchi Z; Nozu K; Yan K; Jüppner H
    JCEM Case Rep; 2023 Mar; 1(2):luad019. PubMed ID: 37908481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymyxin B-induced Bartter syndrome.
    Mohan Lal B; Musthafa Hafeesa N; Vikram NK; Ray A
    BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38702070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradoxical hypertension and salt wasting in Type II Bartter syndrome.
    Chan WK; To KF; Tong JH; Law CW
    Clin Kidney J; 2012 Jun; 5(3):217-20. PubMed ID: 26069767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.